Bank of England Calls Bluff of Bankers Who Threaten to Depart UK

The UK is providing a lesson the US badly needs to learn, that push comes to shove, regulators hold the whip, and have to be willing to use it when necessary. Given how intransigent the financial services industry has become, the time for discipline has come.
Maybe some of them even want it secretly....
In response to a 50% bonus supertax, bankers in the UK are threatening to decamp, as if that will move the authorities to relent. They are not blinking. And with good reason. The idea that everyone ensconced in a large financial firm can decamp to a… ...read more
Featured Author: Yves Smith
Yves Smith has written the popular and trenchant financial blog "Naked Capitalism" since 2006. Yves has spent more than 25 years in the financial services industry and currently heads Aurora Advisors, a New York-based management consulting firm specializing in corporate finance advisory and financial services.
Prior experience includes Goldman Sachs (in corporate finance), McKinsey & Co., and Sumitomo Bank (as head of mergers and acquisitions). Yves has written for publications in the United States and Australia, including The New York Times, The Christian Science Monitor, Slate, The Conference Board Review, Institutional Investor, The Daily Deal and the Australian Financial…
7 articles
Latest Articles
Thu 4:35pm by Edison Investment Research 0 comments
"While trading results fulfilled the promise of the December 2009 trading update, the market seems to be concentrating on the uneven rate of recovery across the groups various markets, rather than Inchcapes medium-term potential and the strong balance sheet. The share price appears to have stabilised over the past six months, but refuses to acknowledge the underlying quality of the overall business which enables management to grow earnings in flat markets."
Thu 3:24pm by Edison Investment Research 0 comments
"SNC-Lavalin is a truly global play with broad-based end markets that allow investors to take a secondary exposure to the upturn across mining, transport infrastructure, oil & gas and power. The performance of the group over the past five years has shown its resilience even in these turbulent economic times with a 30% CAGR in net income and a 28% CAGR in dividends. Likewise, with improved risk management practices following the impact of the poor performing thermal power project in 2007, return on equity has averaged 28% over the past two years. Given the groups ability to transport knowledge from..."
Thu 2:53pm by Edison Investment Research 0 comments
"YM BioSciences has extended its cash runway into 2012 by raising US$17.5m after its February all-stock acquisition of Australian biotech, Cytopia. Cytopia adds two oncology projects (including an oral VDA) to YMs portfolio, and diversifies risk. Nevertheless, potential best-in-class EGFr inhibitor, nimotuzumab, remains central to the investment thesis: read-out of key clinical trials and possible further partnering activity on the back of this suggests that 2010 will be an important year for YM."
Thu 2:28pm by Edison Investment Research 0 comments
"Merrion transforms injected drugs into oral pharmaceuticals, offering relatively low development risk with minimal marketing uncertainty. Final FY09 results on 8 March show strong revenue growth due to payments from Novo on oral insulin and GLP-1 for diabetes. We anticipate a major Orazol deal in Q2-Q3 based on last years clearly indicative Phase II data. The formal grant of the US patent removes a potential uncertainty. Merrion may also sign other deals during 2010. "
Thu 2:19pm by Stockopedia News 1 comment
Thu 2:01pm by Edison Investment Research 0 comments
"Molins shares have rallied significantly from their low point in spring 2009, but they remain materially undervalued relative to larger, UK-based multinational engineering groups. Fears about the pension scheme liabilities should have eased substantially following agreement with the trustees and sentiment ought to improve as the Packaging Machinery division recovers over the next two years."
Thu 1:40pm by Stockopedia News 0 comments
Thu 1:05pm by Edison Investment Research 0 comments
"Results for the year to 31 December 2009 were broadly in line with forecasts and Februarys trading update. EPRA NAV/share in GBP was 14% down for the year overall, at £11.37, but recovered by 7% in H209. Income was stable in local currency, despite a fall in the average occupancy rate, due to increases of up to 5% in rents/sq metre. We covered operational progress including asset sales and refinancing in our recent update. As previously announced, CREO is currently engaged in initiatives to improve its equity rating, ie a tender offer to address a stock overhang, and a proposed..."
Thu 12:35pm by Edison Investment Research 0 comments
"Despite weaker than expected revenues, SQS reported slightly better than forecast FY09 earnings and has seen signs of recovery in several markets. We see FY10 as a recovery year, followed by a year of stronger growth as the companys managed services business gains momentum and the IT services environment improves. The stock trades at c 11x FY10E adjusted EPS with a 3% dividend yield. "
Thu 10:11am by Edison Investment Research 0 comments
"Allocates trading update points out the scale of activity across the quarter to end February, encompassing the Time Care acquisition and a continuing flow of new contract wins, most notably in the healthcare sector. We are not changing our forecasts on the back of the statement, but point out that the expected strong earnings growth in the next full financial year will erode much of the premium. Our DCF indicates a price over £1, which would take better account of the installed base."
Thu 9:00am by Edison Investment Research 0 comments
"Chimes preliminary figures were ahead of expectations, showing organic growth well above the market in all four group activities. International business is now 46% of operating income, through following clients rather than setting up heavy overhead, with the Middle East and Africa key areas. Political uncertainty is the main dampener in all areas as decision making is put on hold. Until that is resolved, consensus earnings are likely to stay on hold, but the rating is nevertheless modest. "
Thu 8:07am by Fox Davies Capital 0 comments
Wed 2:21pm by Fox Davies Capital 0 comments
"Ascent Resources plc, through its subsidiary PetroHungaria kft, has successfully tested and completed the PEN-101 well, in the Penészlek area of the Nyírség exploration permits in eastern Hungary. Once the rig has departed the site, the PEN-105 well will commence production to sales. The completion of the PEN-101 well is, as planned, in a Miocene gas bearing formation within a structure defined on the 3-D seismic acquired in 2008. Initial production rates achieved during preliminary testing exceeded 1.0MMscfd, and productivity is expected to be improved in the coming days by the use..."
Wed 2:14pm by Stockopedia News 0 comments
Wed 9:47am by Edison Investment Research 0 comments
"StatPro has released a solid set of results with revenue and operating profit slightly ahead of our forecasts. We understand the group has been experiencing a significant increase in interest in its new web-based product StatPro Seven, following a revised business model that significantly widens the target customer base, and StatPro Revolution is being launched for beta testing this month. These two new SaaS products have the potential to transform the business at a number of levels."
Wed 9:31am by Fox Davies Capital 0 comments
"Gulf Keystone announced that Kalegran Ltd., a 100% subsidiary of MOL Hungarian Oil and Gas Plc. and the operator of the Akri Bijeel block in Kurdistan, concluded a successful oil test in the Bijeel-1 exploration well in the Akri Bijeel block. The tested zone is in the upper Jurassic and flowed at rates of up to 3,200 bopd with associated gas rates of 933,000scf/d. Oil gravity was 18oAPI and flowing wellhead pressure was 420psi on a 48/64" choke. Drilling operations are still in line with previously announced plans, following completion of the full test cycle, drilling will resume from the..."
Wed 9:19am by Edison Investment Research 0 comments
"PRESEPT study issues have been resolved by sample retesting. The reasons for the outlier results have not been disclosed. The academic steering group has shown that test sensitivity (percentage of true cases) is 62.75%. The specificity is low at 89% (percentage of true negatives). Helpfully, the negative predictive value (NPV) was calculated at 99.7%; this is the probability that a negative test results is really negative. Sadly, the positive predictive value (PPV), the chance that a positive SEPT9 result is true, was not estimated. To be helpful, we calculate this at 3.56%."
Wed 8:40am by Edison Investment Research 0 comments
"In spite of the challenging market conditions, management notes there are signals that the pace in market activity is now increasing and we believe Brady is well placed to build on the momentum it has achieved over the last two years. The pipeline remains strong, support is being expanded to service global clients, and the group is positioned to benefit from the growing quality and scale of customers."
Wed 8:05am by Stockopedia News 3 comments
Wed 7:19am by valueinvestor 0 comments
